CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice

Electronic Manufacturing Batch Records and Digitalisation in Biopharmaceutical Manufacturing

In response to the evolving expectations of the biopharmaceutical industry, contract manufacturing organisations (CMOs) are facing mounting pressure to optimise processes, uphold data integrity, and scale operations. Traditional paperbased manufacturing batch record (pMBR) practices have become barriers to agility. They limit process visibility, introduce transcription and review errors, and generate bottlenecks that can delay batch release and delivery.

The growing regulatory requirements for ALCOA++ principles, quality, and safety have pushed the industry to transition from paperbased to digitalised record systems, known as electronic batch records, often referred to as electronic manufacturing batch records (eMBRs). Through eMBRs, biomanufacturers can secure data traceability, achieve realtime process oversight, and enable faster, more reliable operations. However, the digital transition has faced roadblocks due to the lack of systematic know-how and expertise.

eMBR systems electronically manage data flow related to operations on the production floor. Unlike paper records that require human transcription, eMBRs interface with various data platforms – enterprise resource planning systems, laboratory information management systems (LIMS), manufacturing execution systems (MES), equipment control systems (distributed control system or individual programmable logic controller), and quality management systems. This interconnectivity enables real-time data flow across business, manufacturing, and quality operations.

Critically, eMBRs support the execution of manufacturing processes step by step through validated, standardised templates. They reinforce procedural adherence, eliminate transcription mistakes, enable immediate access to records, and address key vulnerabilities of paper-based systems. By safeguarding record integrity and providing a robust audit trail, eMBRs generate trustworthy data that meet the expectations of global authorities, such as the U.S. Food and Drug Administration and European Medicines Agency.

Challenges in Traditional Batch Record Management

Historically, pMBR has relied on manual document preparation, change management, and data entry. Operators consult multiple external systems, write down process information on paper, and later transfer the data to other systems. All activities are cross verified, then reviewed by the quality team to ensure integrity. These procedures are timeintensive, error-prone, and dependent on human vigilance.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026